STAGE IIIA PRIMARY PERITONEAL CANCER AJCC V7
Clinical trials for STAGE IIIA PRIMARY PERITONEAL CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA PRIMARY PERITONEAL CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIIA PRIMARY PERITONEAL CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Hard-to-Treat brain tumors in early trial
Disease control OngoingThis early-phase study tests a new drug (MLN0128) combined with bevacizumab in 50 adults with recurrent glioblastoma or other advanced solid tumors that have not responded to standard treatments. The goal is to find the safest dose and understand side effects. The drug combo aims…
Matched conditions: STAGE IIIA PRIMARY PERITONEAL CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 01, 2026 17:42 UTC
-
Heated chemo during surgery shows promise for Tough-to-Treat cancers
Disease control OngoingThis early-stage trial tests the safety and effectiveness of giving heated chemotherapy directly into the abdomen during surgery for advanced or recurrent ovarian, fallopian tube, uterine, or peritoneal cancers. About 40 participants receive this treatment, and some may also get …
Matched conditions: STAGE IIIA PRIMARY PERITONEAL CANCER AJCC V7
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Ovarian cancer drug study aims to unlock DNA secrets before surgery
Knowledge-focused OngoingThis early-phase study looks at how the drug adavosertib changes the DNA of advanced ovarian, fallopian tube, or peritoneal cancer in 38 patients before they have surgery. The goal is to understand how the drug affects tumor cells, not to cure or control the disease directly. Res…
Matched conditions: STAGE IIIA PRIMARY PERITONEAL CANCER AJCC V7
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:51 UTC